Correlation Between Swedish Orphan and Amgen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Swedish Orphan and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swedish Orphan and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Swedish Orphan Biovitrum and Amgen Inc, you can compare the effects of market volatilities on Swedish Orphan and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swedish Orphan with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swedish Orphan and Amgen.

Diversification Opportunities for Swedish Orphan and Amgen

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Swedish and Amgen is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Swedish Orphan Biovitrum and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Swedish Orphan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swedish Orphan Biovitrum are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Swedish Orphan i.e., Swedish Orphan and Amgen go up and down completely randomly.

Pair Corralation between Swedish Orphan and Amgen

Assuming the 90 days horizon Swedish Orphan Biovitrum is expected to under-perform the Amgen. In addition to that, Swedish Orphan is 2.0 times more volatile than Amgen Inc. It trades about -0.32 of its total potential returns per unit of risk. Amgen Inc is currently generating about -0.12 per unit of volatility. If you would invest  28,177  in Amgen Inc on January 26, 2024 and sell it today you would lose (876.00) from holding Amgen Inc or give up 3.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Swedish Orphan Biovitrum  vs.  Amgen Inc

 Performance 
       Timeline  
Swedish Orphan Biovitrum 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Swedish Orphan Biovitrum has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Swedish Orphan and Amgen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Swedish Orphan and Amgen

The main advantage of trading using opposite Swedish Orphan and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swedish Orphan position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.
The idea behind Swedish Orphan Biovitrum and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stocks Directory
Find actively traded stocks across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities